iSTOC has established a new partnership in Europe with Siemens Healthineers, to support healthcare providers to deploy large scale rapid testing for COVID-19. The combination of a rapid COVID-19 antigen test from Siemens Healthineers and the iSTOC IDA diagnostics solution can help countries to put in place effective testing strategies, that are essential to manage the pandemic and stop the spread of COVID-19.
“Rapid tests are deployed in decentralized locations such as white tents, field hospitals, small clinics, geriatric care homes, airports and manufacturing facilities, where the normal infrastructure of testing laboratories is not available. Therefore, a reliable, easy to use test is required,” states Rupert Smith-Moorhouse, Head of Point of Care Testing at Siemens Healthineers in the Nordic and Baltic countries.
“Once the test results have been obtained, they need to be captured and made available for healthcare professionals to ensure appropriate follow up and management of positive COVID-19 patients. Data aggregation is important to track the spread of the virus and to review trends across regions and countries in real-time,” Smith-Moorhouse continues.
The combination of an easy to use, reliable rapid test from Siemens Healthineers and a quick data capture with the use of iSTOC mobile app represents a new opportunity in COVID-19 testing, and will be a very effective tool in managing the pandemic. The rapid antigen test takes only 15 minutes to give the results, and the data from the app can easily be aggregated and analyzed in a software program. The solution is compliant with all data privacy regulations in the Nordic and Baltic countries, and the iSTOC IDA solution is CE-marked, and FDA approved.
”Fast, large scale testing is essential in managing the pandemic, and can support countries, cities and workplaces to reopen, enabling people to return to normal life as soon as possible,” states Jarmo Järvenpää, CEO of iSTOC. Reading the test results using machine vision and digitizing them minimizes human errors, as IDA solution scans and saves the results of rapid tests in real-time, to a safe cloud server, for diagnostics and analytics.
“With large data volume for the tests conducted, iSTOC real-time AI driven data analytics facilitates predictive analytics for the monitoring, control and policy-decision making for the eradication of COVID-19,” says Sayed Jawed, Sales Director of iSTOC.
Siemens Healthineers AG is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology.
The CLINITEST Rapid COVID-19 Antigen Test is easy to administer for healthcare professionals and delivers results quickly using the nasopharyngeal swab method. Once a sample is collected, the swab is inserted into a tube with special liquid to extract the target molecule. This liquid is then dispensed onto a test cassette and, in 15 minutes, a positive or negative result is clearly indicated. With specificity of 99.22% and sensitivity of 96.72%, you can feel confident in reliable results. Studies performed by the developer (across a number of sites, clinical environments, and operators) demonstrated high quality performance data.
iSTOC integrates Point of Care diagnostics, machine vision, mobile technology and cloud computing into one reliable platform. iSTOC turns a smart phone into an easy-to-use medical device for point-of-care testing. iSTOC IDA scans and saves the results of rapid tests to a safe cloud server for diagnostics and analytics. iSTOC IDA solution uses patented technology and is also HIPAA compliant.
More information: email@example.com